Categories: AnalystsSoftware

Despite recent run OpenText is still undervalued, says Cormark’s Tse


Attendees of this year’s OpenText user conference in Orlando may be distracted by keynote speaker William Shatner, but Cormark analyst Richard Tse is focused on the company’s potential for growth from its recent acquisition of GXS Group.
After announcing the $1.16-billion acquisition of GXS Group on November 5th, shares of OpenText (TSX:OTC) have gone on a run. But investors still aren’t pricing in all the potential the company has for both organic growth and growth through acquisition, says Cormark Securities analyst Richard Tse.

OpenText’s annual user conference, Enterprise World, ends today in Orlando Florida. While many might be distracted by the events keynote speaker -none other than Captain Kirk himself, William Shatner, Tse is focused on Red Oxygen and Blue Carbon.

Red Oxygen and Blue Carbon, respectively, are code names for OpenText’s current line of products and a future line of products that build on the former.

Tse says there is simultaneously reason to be excited about new products from OpenText and reason for caution. He believes new products have the potential to drive organic growth, but wonders aloud about the company’s recent track record on organic growth and the details on how they will achieve it going forward.

But in the short term, says Tse, questions about Blue Carbon are somewhat irrelevant because the market still isn’t fully pricing in the potential growth from the GXS acquisition. The Cormark analyst says he sees “considerable” synergies from the pickup, including lower finance costs and interest savings. His initial estimates have the company tacking on between $0.80-1.20 in EPS within the first year alone.

In a research update to clients yesterday, maintained his BUY rating and $95.00 one-year target on OpenText. At press time, shares of the company on the TSX were down .7% to $88.28.

______________

Tagged with: OTC
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

This Canadian microcap tech stock has massive upside, analyst says

Research Capital analyst Greg McLeish reiterated his “Speculative Buy” rating and $3.00 target on The FUTR Corporation (The FUTR Corporation… [Read More]

2 hours ago

Should you sell your BRP stock?

TD Cowen analyst Brian Morrison downgraded BRP  (BRP Stock Quote, Chart, News, Analysts, Financials TSX:DOO) to “Hold” from “Buy” and… [Read More]

7 hours ago

Constellation Software is “misunderstood” right now, this investor says

In an appearance on BNN Bloomberg Market Call on April 14, Raymond James Investment Counsel portfolio manager Chris Blumas said… [Read More]

9 hours ago

Buy MDA Space? Here’s what this analyst thinks

Beacon analyst Russell Stanley maintained his “Buy” rating on MDA Space (MDA Space Stock Quote, Chart, News, Analysts, Financials TSX:MDA)… [Read More]

12 hours ago

Merlin Labs is undervalued, this analyst says

Roth Capital Markets initiated coverage of Merlin Labs (Merlin Labs Stock Quote, Chart, News, Analysts, Financials NASDAQ:MRLN) with a “Buy”… [Read More]

13 hours ago

Acumen Capital likes NeuPath Health right now

Acumen Capital analyst Nick Corcoran has initiated coverage of NeuPath Health (NeuPath Health Stock Quote, Chart, News, Analysts, Financials TSXV:NPTH)… [Read More]

1 day ago